Tuesday 5 September 2017
Royal Society of Medicine
1 Wimpole Street
Online registration is closed but places are available on the day. Please email email@example.com with any questions or queries.
Organised in collaboration with researchers at Imperial College London, book your place to attend this highly relevant meeting about the new world of the microbiome in medicine, with a focus on microbes in cancer aetiology and therapeutics.
This is a highly relevant topic for trainees of all disciplines as the microbiome represents a developing field that is likely to become increasingly relevant in day-to-day clinical practice.
The microbiome refers to the collective genome of our 100 trillion strong host of resident bacteria, yeasts and viruses which cultivate every niche of our bodies. This internal ecosystem has garnered increasing interest for its role in development, immune regulation and metabolism and is starting to be considered an organ system.
Trainees of all disciplines are invited to join this one-day meeting that will explore the role of the microbiome in the pathogenesis of cancer, the current state of knowledge and how this research could shape the future of clinical practice.
Professor Julian Marchesi
Deputy Director and Professor of Clinical Microbiome Research, Centre for Digestive and Gut Health, Imperial College London
Professor Christian Jobin
Professor of Medicine and Programme Leader, Cancer Microbiota and Host Response, Health Cancer Centre, Division of Gastroenterology, Hepatology and Nutrition, University of Florida College of Medicine, USA
Professor Robert Brown
Chair in Translational Oncology and Head of Division of Cancer, Department of Surgery and Cancer, Imperial College London and Professor in Translational Oncology, Institute of Cancer Research, London, UK
Mr James Kinross, Senior Lecturer and Consultant in Colorectal Surgery, Imperial College London
Session one: Introduction to the microbiome
Introduction to meta ‘omics: Technology and science
Professor Julian Marchesi, Professor of Digestive Health and Deputy Director, Centre for Digestive and Gut Health, Imperial College London and Professor in Human Microbiome Research, Cardiff University
Current paradigms in colorectal carcinogenesis
Dr Harpreet Wasan, GI Lead for Medical Oncology, Hammersmith Hospital and Imperial College Healthcare NHS Trust
Carcinogenesis: A microbiome related disease?
Professor Christian Jobin, Professor of Medicine and Programme Leader, Cancer Microbiota and Host Response, Health Cancer Center, Division of Gastroenterology, Hepatology, and Nutrition, University of Florida College of Medicine, USA
Microbial sulphur metabolism and colorectal cancer risk
Professor Rex Gaskins, Professor of Immunobiology, University of Illinois at Urbana-Champaign, USA
Questions and answers
Tea and coffee break
Session two: The microbiome and carcinogenesis: Driver or passenger?
Professor Julian Marchesi
Expert panel debate
Professor Robert Brown, Chair in Translational Oncology and Head of Division of Cancer, Department of Surgery and Cancer, Imperial College London, Professor Luis Muir, Professor and Director of Research of the Biology and Health Theme, Aberystwyth University, Wales, Dr David Hughes, Honorary Lecturer, Centre for Systems Medicine, RCSI Physiology & Medical Physics Department, Royal College of Surgeons in Ireland and Professor Christian Jobin
Lunch with poster exhibition
Session three: The microbiome and disease
Professor Julian Teare, Consultant Gastroenterologist and Professor of Gastroenterology, Imperial College London, UK
Functional anatomy of the colonic bioreactor in health and disease
Dr Alex Swidsinski, Laboratory for Molecular Genetics, Polymicrobial Infections and Biofilms, Department of Medicine, Section of Gastroenterology, Hepatology and Endocrinology, Charité Universitätsmedizin Berlin, Germany
The vaginal microbiome and progression to neoplasia
Prof Hans Verstraelen, Department of Obstetrics and Gynaecology, Vulvovaginal Disease Clinic, Ghent University Hospital, Ghent, Belgium
The upper and lower respiratory tract microbiome in the diagnosis of respiratory disease
Prof Luis Mur, Professor and Director of Research of the Biology and Health Theme, Aberystwyth University, Wales
The microbiota in inflammatory bowel disease
Professor Daniel Rosenberg, Professor of Medicine, Centre for Molecular Medicine, University of Connecticut Health Centre, USA
Could the urinary and intestinal microbiomes have a role in urologic cancers?
Professor Jeremy Burton, Miriam Burnett Chair in Urological Sciences and Deputy Director of the Canadian Centre for Human Microbiome and Probiotics, Lawson Health Research Institute, Canada
Professor Daniel Rosenberg
Tea and coffee break
Session four: The microbiome and therapeutics
Faecal microbiome analysis in clinical practice: Are we ready?
Mr James Kinross
Cutting edge: The microbiome and surgery
Professor John Alverdy, Sarah and Harold Lincoln Thompson Professor of Surgery, Executive Vice-Chair, Department of Surgery, University of Chicago USA
Faecal microbiota transplant
Dr Benjamin Mullish, Head of UK FMT Guideline Development, Imperial College Cancer UK
Dietary manipulation, prebiotics and probiotics and the microbiome
Dr Stephen O’Keefe, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh, USA
Question and answers
Networking drinks reception
View rates for all membership types:View rates
For information on this event, contact Amy StrattonTel: 02072902980 Fax: 02072902989 Email: firstname.lastname@example.org